Continued debate is fine, but the vaccine is inexpensive and the risk is not worth taking with
my flock. The information below is from Wikipedia. Please read the green sentences that say it spreads by dander and that newer vaccines are a combination of turkey and chicken marek's. I still believe the lady I bought from is correct, because she has seen customers mix flocks and loss birds. If we are wrong then we have only erred on the side of caution.
Marek's disease is a highly contagious
viral neoplastic disease in
chickens. It is named after
József Marek, a Hungarian veterinarian. Occasionally misdiagnosed as an
abtissue pathology it is caused by an
alphaherpesvirus known as 'Marek's disease virus' (MDV) or
Gallid herpesvirus 2 (GaHV-2). The disease is characterized by the presence of
T cell lymphoma as well as infiltration of
nerves and
organs by
lymphocytes. Viruses related to MDV appear to be benign and can be used as vaccine strains to prevent Marek's disease. For example, the related Herpesvirus of Turkeys (HVT), causes no apparent disease in turkeys and continues to be used as a vaccine strain for prevention of Marek's disease (see below). Birds infected with GaHV-2 can be carriers and shedders of the virus for life. Newborn chicks are protected by
maternal antibodies for a few weeks. After infection, microscopic lesions are present after one to two weeks, and gross lesions are present after three to four weeks.
The virus is spread in dander from feather follicles and transmitted by inhalation.
Prevention
Vaccination is the only known method to prevent the development of
tumors when chickens are infected with the virus. However, administration of vaccines does not prevent transmission of the virus, i.e., the vaccine is non-sterilizing. However, it does reduce the amount of virus shed in the dander and hence reduce horizontal spread of the disease. Marek's Disease does not spread vertically. The vaccine was introduced in 1970 and the scientist credited with its development is Dr. Ben Roy Burmester. Before that, Marek's disease caused substantial revenue loss in the poultry industries of the United States and the United Kingdom. The vaccine can be administered to one day old chicks through sub-cutaneous inoculation or by in-ovo vaccination when the eggs are transferred from the incubator to the hatcher. In-ovo vaccination is the preferred method, as it does not require handling of the chicks and can be done rapidly by automated methods. Immunity develops within two weeks.
The vaccine originally contained the
antigenically similar
turkey herpesvirus, which is
serotype 3 of MDV. However, because vaccination does not prevent infection with the virus, the Marek's Disease virus has evolved increased virulence and resistance to this vaccine.
As a result, current vaccines use a combination of vaccines consisting of HVT and gallid herpesvirus type 3 or an attenuated MDV strain, CVI988-Rispens (ATCvet code: QI01AD03).